A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer (Q39910365)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer
scientific article

    Statements

    A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit